Back to search results
NCT06679803

Feasibility of a First-Line Physical Activity Intervention After Stroke

Active, Not Recruiting
NAAges 18+InterventionalTreatment
University of Minnesota
~21 participants
Updated 2026-09-10 on ClinicalTrials.gov
What's tested:Physical Activity Chats after Stroke (PA-ChatS)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to PA-ChatS sessions
Measured over 6-weeks
+1 more outcome measured

Conditions

Stroke
Ischemic Stroke
Hemorrhagic Stroke

Explore related trials

Stroke

NCT06679803

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Minnesota

    Minneapolis, Minnesotano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Emily Kringle, PhD, OTR/L · PRINCIPAL_INVESTIGATOR · University of Minnesota

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Stroke diagnosis confirmed by imaging
Admitted to Fairview Health System (Minnesota) at the time of study enrollment or discharged to a community-based setting from Fairview Health System within 3 months before study enrollment
Able and willing to participate fully in the study and provide informed consent or proxy consent with participant assent

Exclusion

Discharge anticipated to a transitional care unit, skilled nursing facility, or other non-community-based care setting
Severe cognitive or communication impairments (inability to respond accurately to complete study screening questions or to provide informed consent or assent
Comorbid neurological disorder (Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma, spinal cord injury, cerebral palsy)
Comorbid cancer, currently undergoing chemotherapy or radiation treatment
Received inpatient treatment or was hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
Current diagnosis of a terimnal illness and/or receiving hospice care
History of allergic reaction to adhesives that precludes the use of an adhesive necessary for adherence to activPAL measurement
Inability to speak, read, or understand English
Concurrent participation in another rehabilitation intervention research study
Resides more than 50 miles outside of the Twin Cities metropolitan area
Investigator discretion for safety or adherence reasons

What this trial measures

  • Adherence to PA-ChatS sessions6-weeks

    Percentage of participants who complete 6 out of 6 (100%) of PA-ChatS sessions. Session completion will be documented by the study intervention therapist and total count of sessions completed will be computed after the last intervention session is delivered.

  • Adherence to wearable activity tracker6-weeks

    Percentage of participants who use the wearable activity tracker (Fitbit Inspire 3) an average of 5 of 7 days/week during the 6-week intervention period. Data will be exported from Fitbit to compute average number of days per week the Fitbit was used.